Skip to content

CMTA Press Room

Official News From Charcot-Marie-Tooth Association

CMTA’s Press Room Is Where We Share News That Shapes Not Only the Future of CMT Research but Real Impact Today. From Funding Announcements to Trial Updates, This Is Where Progress Moves From Idea to Action.


  • Charcot-Marie-Tooth Association Appoints Catie Coman as Chief Marketing Officer

    CMTA Appoints Catie Coman Chief Marketing Officer

    Coman brings more than 15 years of experience in patient advocacy and has worked with…

  • CMTA Invests $281,339 to Advance Treatments for CMT1A

    CMTA Invests $281,339 to Advance Treatments for CMT1A

    The newly funded study will test whether molecules originally in development as cancer therapeutics can…

  • CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery

    $210K to Unlock CMT Gene Discoveries

    CMTA is investing $210,000 in long-read sequencing to uncover hidden gene mutations in undiagnosed CMT…

  • CMTA Invests $423K in Transformative Genomic Research to Advance CMT Diagnostics

    Solving CMT: CMTA Invests $423K in Gene Discovery

    CMTA is investing $423,000 in advanced genomic research to close diagnostic gaps in CMT and…

  • CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types

    CMTA and INC Forge New Alliance

    What happens when the world’s largest CMT funder joins forces with the leading clinical research…

Your Pathway Doesn’t End Here. Your Journey Continues.

Where to Next?